简介:在由惊奇到平常、由激动到平静、由陌生到熟悉的递变里,时光悄然滑落。转眼工夫,我已然大四了,还清晰记得三年前,那一次偶然的邂逅让我与社团、与绿色生命环境发展协会结缘,就像小说里写的那样,很戏剧。可就在那一瞬间,绿色、社团的激情点燃了我,于是从此一发不可收拾。让我为她奔走,为她忙碌……
简介:AIM:Toevaluatethelong-termresultsandcomplicationsofahmedglaucomavalve(AGV)implantationinrefractoryglaucoma.·METHODS:Aretrospectivereviewof13patients(13eyes)withrefractoryglaucomawhounderwentAGVimplantationandhadaminimumfollow-upof18monthswasperformed.Allpatientsunderwentacompleteophthalmologicexaminationandintraocularpressure(IOP)measurementbeforesurgeryandat1month,3months,6months,1yearaftersurgeryandyearlyafterwards.Complicationsandthenumberofantiglaucomamedicationsneededwererecorded.·RESULTS:Meanagewas27.3±16.0years.Alleyes(100%)hadatleastonepriorincisionalsurgery.Meanfollow-upwas61.3±30.8months.IOPwasreducedfromameanof35.0±7.0mmHgto18.2±7.9mmHgat12monthsandto17.0±4.1mmHgat96months(P<0.05)withalowernumberofmedicationsfrombaseline,76.9%patientsrequiredadditionalprocedurestoachievethesuccesscriteriasetbypreviouslypublishedseries.Themostcommoncomplicationswereencapculatedcystformationineighteyes(61.5%)andtubeexposureinfoureyes(30.8%).·CONCLUSION:EncapsulatedcystformationwasthemostcommoncomplicationwhichhinderedsuccesfulIOPcontrolafterAGVimplantinsertionforrefractoryglaucoma.Despitecystexcisionwithanti-fibroticagents,successfulIOPreductionwasnotachievedin76.9%ofthepatientswithoutantiglaucomamedication.
简介:从多刺绿绒蒿MeconopsishorridulaHook.f.etThoms的全草中分离鉴定了13个化合物,分别为:木犀草素-7-O-β-D-葡萄糖苷(1)、山奈酚-3-O-β-D-葡萄糖(1→2)-β-D-葡萄糖苷(2)、槲皮素-3-O-β-D-半乳糖(1→6)-β-D-葡萄糖苷(3)、小麦黄素-7-O-β-D-葡萄糖苷(4)、山奈酚-3-O-β-D-葡萄糖(5)、桂皮酰胺(6)、对羟基桂皮酰胺对羟基苯乙胺(7)、小麦黄素(8)、木犀草素(9)、槲皮素(10)、芹菜素(11)、山奈酚-4′-甲醚(12)、山奈酚(13)。其中化合物1、5、6、7、12、13为首次从该属中分离得到,化合物2、3、4为首次从该植物中分离得到。